Blueprint Medicines Corporation is a biopharmaceutical company based in Cambridge, MA that focuses on developing precision therapies for patients with genomically defined diseases.
Utilizing a targeted approach, the company aims to create innovative treatments that address the underlying genetic drivers of various cancers and rare diseases.
Generated from their business information